SAM
MDLN

SEB Asset Management’s Medline Inc MDLN Stock Holding History

SEB Asset Management’s Portfolio MDLN Stock Details MDLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.41M Buy
+162,433
New +$6.55M 0.02% 414

Other funds holding MDLN

CG
Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return
HFCIX
H&F Corporate Investors X San Francisco, California $2.8B AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
ECU
Egerton Capital (UK) London, United Kingdom $10.4B AUM 25.66% 1-Year Est. Return

SEB Asset Management's MDLN Position: Q2 2026 in Review

SEB Asset Management opened a new position in Medline Inc (MDLN) in Q2 2026: 162,433 shares worth $6.41M. The stake represents 0.02% of the portfolio and ranks #414 among its holdings.

376 funds tracked by Wall St. Rank hold MDLN as of Q2 2026.

  • SEB Asset Management held 162,433 shares of Medline Inc worth $6.41M as of Q2 2026.
  • Medline Inc was a new SEB Asset Management position in Q2 2026.
  • Medline Inc made up 0.02% of SEB Asset Management's portfolio in Q2 2026, its #414 holding.
  • 376 funds tracked by Wall St. Rank held Medline Inc as of Q2 2026.

Based on SEB Asset Management's 13F filing for Q2 2026, filed 4 Aug 2026.